Ocrevus off to a flying start as Roche raises 2017 forecasts

The take-up of the drug has been buoyed by trials showing that the drug outperformed Merck KGaA's MS stalwart Rebif (interferon beta-1a) in two relapsing MS phase III

CHMP backs three immuno-oncology drugs for solid tumours

Roche, MSD and Merck KGAA/Pfizer all picked up positive opinions for cancer immunotherapies from EMA advisors last week, setting up approvals in the third quarter. ... The Committee for Medicinal Products for Human Use (CHMP) recommended approval of

Celgene joins PD-1 race via partnership with BeiGene

It will have a long way to go to catch the leaders in the PD-1/PD-L1 category however, as first entrants Bristol-Myers Squibb and Merck &Co have been ... joined by Roche, Merck KGaA/Pfizer and AstraZeneca in recent months, and all the players have dozens

The Owen Group launches healthcare agency Owen

The newly-established agency has worked with global healthcare players on various projects including building iPad applications for Novartis and Merck-Serono, a digital marketing store for Pfizer and producing a

Result pages: 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 (Next 5)